Goldman Sachs Group Inc Mannkind Corp Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Mannkind Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,213,655 shares of MNKD stock, worth $13.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,213,655

Previous 1,790,490 23.63%

Holding current value

$13.3 Million

Previous $9.35 Million 48.74%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $2.12 Million - $2.84 Million	423,165 Added 23.63%	2,213,655 $13.9 Million
Q2 2024 Aug 13, 2024	BUY	$4.05 - $5.43 $2.42 Million - $3.24 Million	597,185 Added 50.04%	1,790,490 $9.35 Million
Q1 2024 May 15, 2024	SELL	$3.25 - $5.27 $6.01 Million - $9.75 Million	-1,849,562 Reduced 60.78%	1,193,305 $5.41 Million
Q4 2023 Feb 13, 2024	BUY	$3.34 - $4.29 $1.12 Million - $1.44 Million	336,257 Added 12.42%	3,042,867 $11.1 Million
Q3 2023 May 14, 2024	SELL	$3.91 - $5.45 $1.31 Million - $1.83 Million	-336,257 Reduced 11.05%	2,706,610 $11.2 Million
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $5.07 Million - $7.07 Million	1,297,132 Added 92.03%	2,706,610 $11.2 Million
Q2 2023 May 14, 2024	SELL	$3.72 - $4.79 $703,232 - $905,506	-189,041 Reduced 11.83%	1,409,478 $5.74 Million
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $703,232 - $905,506	-189,041 Reduced 11.83%	1,409,478 $5.74 Million
Q1 2023 May 14, 2024	BUY	$3.95 - $5.63 $1.7 Million - $2.43 Million	430,921 Added 36.91%	1,598,519 $6.55 Million
Q1 2023 May 11, 2023	BUY	$3.95 - $5.63 $1.7 Million - $2.43 Million	430,921 Added 36.91%	1,598,519 $6.55 Million
Q4 2022 May 14, 2024	SELL	$3.02 - $5.37 $2.05 Million - $3.65 Million	-679,290 Reduced 36.78%	1,167,598 $6.15 Million
Q4 2022 Feb 13, 2023	SELL	$3.02 - $5.37 $2.05 Million - $3.65 Million	-679,290 Reduced 36.78%	1,167,598 $6.15 Million
Q3 2022 May 14, 2024	SELL	$2.99 - $4.35 $1.89 Million - $2.75 Million	-632,630 Reduced 25.51%	1,846,888 $5.71 Million
Q3 2022 Nov 10, 2022	SELL	$2.99 - $4.35 $1.89 Million - $2.75 Million	-632,630 Reduced 25.51%	1,846,888 $5.71 Million
Q2 2022 May 14, 2024	SELL	$2.67 - $4.77 $1.5 Million - $2.69 Million	-563,349 Reduced 18.51%	2,479,518 $9.45 Million
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $1.69 Million - $3.02 Million	632,600 Added 34.25%	2,479,518 $9.45 Million
Q1 2022 May 16, 2022	BUY	$2.62 - $4.45 $674,959 - $1.15 Million	257,618 Added 16.21%	1,846,918 $6.8 Million
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $685,814 - $909,339	169,337 Added 11.93%	1,589,300 $6.95 Million
Q3 2021 Nov 10, 2021	BUY	$3.89 - $5.48 $5.52 Million - $7.78 Million	1,419,963 New	1,419,963 $6.18 Million

Others Institutions Holding MNKD

# of Institutions

242

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.55B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Mannkind Corp Transaction History